[1] Li N,Li J,Ding Y,et al.Novel mutations in the CYP11B2 gene causing aldosterone synthase deficiency[J].Mol Med Rep,2016,13(4):3127-3132.
[2] Ur Rehman S,Aftab S,Naseem A,et al.Corticosteronemethyl oxidase type 1 (CMO1) deficiency due to CYP11B2 mutation:Two case reports[J].Cureus,2023,15(5):e39181.
[3] Wi JY,Ma HM,Zhang J,et al.Aldosterone signaling defect in young infants:Single-center report and review[J].BMC Endocr Disord,2021,21(1):149.
[4] Miao H,Yu Z,Lu L,et al.Analysis of novel heterozygous mutations in the CYP11B2 gene causing congenital aldosterone synthase deficiency and literature review[J].Steroids,2019,150:108448.
[5] Christina M,Irene F,Amalia S,et al.Molecular Analysis of the CYP11B2 Gene in 62 Patients with hypoaldosteronism due to aldosterone synthase deficiency[J].J Clin Endocrinol Metab,2021,106(1):e182-e191.
[6] Faingelernt Y,Hershkovitz E,Abu-Libdeh B,et al.Aldosterone synthase (CYP11B2) deficiency amongpalestinian infants:Three novel variants and genetic heterogeneity[J].Am J Med Genet A,2021,185(4):1033-1038.
[7] Turan H,Akr A D,Zer Y,et al.Clinical and genetic characteristics of patients with corticosterone methyloxidase deficiency type 2:Novel mutations in CYP11B2[J].Journal of Clinical Research in Pediatric Endocrinology,2020,13(2):232-238.
[8] Hui E,Yeung MC,Cheung PT,et al.The clinical significance of aldosterone synthase deficiency:Report of a novel mutation in the CYP11B2 gene[J].BMC Endocr Disord,2014,14(1):29.
[9] Garrelfs MR,Rinne T,Hillebrand JJ,et al.Identification of anovel CYP11B2 variant in a family with varying degrees of aldosterone synthase deficiency[J].J Clin Res Pediatr Endocrinol,2024,16(1):95-101.
[10] Schiffer L,Anderko S,Hannemann F,et al.The CYP11B subfamily[J].J Steroid Biochem Mol Biol,2015,151:38-51.
[11] 杨海花,陈琼,张璐,等.一例醛固酮合成酶缺乏症患儿的临床及基因变异分析[J].中华医学遗传学杂志,2021,38(9):4.
Yang HH,Chen Q,Zhang L,et al.Clinical and genetic variation analysis of a child with aldosterone synthetase deficiency[J].Chinese Journal of Medical Genetics,2021,38(9):4.(in Chinese)
[12] 赵方圆.1例CYP11B2基因突变导致醛固酮合成酶缺乏症的临床分析[D].杭州:浙江大学,2019.
Zhao FY.Clinical analysis of a case of aldosterone synthetase deficiency caused by CYP11B2 gene mutation [D].Hangzhou:Zhejiang University,2019.(in Chinese)
[13] 徐爱晶,梅慧芬,程静,等.CYP11B2基因突变致醛固酮合成酶缺乏症一例并文献复习[J].中国小儿急救医学,2023,30(1):68-71.
Xu AJ,Mei HF,Cheng J,et al.A case study of aldosterone synthetase deficiency induced by CYP11B2 gene mutation and literature review[J].Chinese Journal of Pediatric Emergency Medicine,2019,30(1):68-71.(in Chinese)
[14] Takeda Y,Demura M,Kometani M,et al.Molecular and epigenetic control of aldosterone synthase,CYP11B2 and 11-hydroxylase,CYP11B1[J].Int J Mol Sci,2023,24(6):5782.
[15] Wu,YC,Chen,CI,Chen,PY,et al.GRAde:A long-read sequencing approach to efficiently identifying the CYP11B1/CYP11B2 chimeric form in patients with glucocorticoid-remediable aldosteronism[J].BMC Bioinformatics.2022,22 (Suppl 10):613.
[16] Cai W,Yu D,Gao J,et al.Clinical presentation and genetic analysis of neonatal 11β-Hydroxylase deficiency induced by a chimeric CYP11B2/CYP11B1 gene[J].J Clin Res Pediatr Endocrinol,2024,16(3):372-378.
[17] Gurpinar TB,Kendir DY,Seven MT,et al.Catch-up growth and discontinuation of fludrocortisone treatment in aldosterone synthase deficiency[J].J Clin Endocr Metab,2022,107 (1):e106-e117.